Dashboard
Manage Tickers

TARA Protara Therapeutics, Inc.

Nasdaq protaratx.com


$ 6.63 $ 0.21 (3.26 %)    

Friday, 21-Nov-2025 09:53:50 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 589.00 $ 1.67 (0.28 %)
DIA $ 459.06 $ -0.41 (-0.09 %)
SPY $ 656.00 $ 1.02 (0.16 %)
TLT $ 89.51 $ -0.15 (-0.17 %)
GLD $ 374.72 $ 0.73 (0.2 %)
$ 6.44
$ 6.65
$ 6.65 x 109
$ 6.68 x 202
$ 6.60 - $ 6.65
$ 2.28 - $ 10.48
1,032,347
na
272.23M
$ 1.56
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2025 09-30-2025 10-Q
2 08-11-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 03-05-2025 01-01-1970 10-K
5 11-12-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-02-2024 03-31-2024 10-Q
8 03-13-2024 12-31-2023 10-K
9 11-03-2023 09-30-2023 10-Q
10 08-03-2023 06-30-2023 10-Q
11 05-04-2023 03-31-2023 10-Q
12 03-08-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-09-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 03-09-2022 12-31-2021 10-K
17 11-04-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 03-11-2021 12-31-2020 10-K
21 11-12-2020 09-30-2020 10-Q
22 07-31-2020 06-30-2020 10-Q
23 05-13-2020 03-31-2020 10-Q
24 03-20-2020 12-31-2019 10-K
25 10-31-2019 09-30-2019 10-Q
26 08-07-2019 06-30-2019 10-Q
27 05-08-2019 03-31-2019 10-Q
28 03-13-2019 12-31-2018 10-K
29 11-07-2018 09-30-2018 10-Q
30 08-07-2018 06-30-2018 10-Q
31 05-09-2018 03-31-2018 10-Q
32 03-14-2018 12-31-2017 10-K
33 11-07-2017 09-30-2017 10-Q
34 08-07-2017 06-30-2017 10-Q
35 05-10-2017 03-31-2017 10-Q
36 03-16-2017 12-31-2016 10-K
37 11-07-2016 09-30-2016 10-Q
38 08-08-2016 06-30-2016 10-Q
39 05-09-2016 03-31-2016 10-Q
40 03-14-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

whats-going-on-with-protara-therapeutics-stock-wednesday
What's Going On With Protara Therapeutics ...
11/19/2025 19:18:12

TARA-002, a cell-based therapy by Protara Therapeutics, shows promising results in treating lymphatic malformations in pediatri...

hc-wainwright--co-reiterates-buy-on-protara-therapeutics-maintains-23-price-target
HC Wainwright & Co. Reiterates Buy on Prot...
11/19/2025 16:37:40

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Protara Therapeutics (NASDAQ:TARA) with a Buy and maintains $...

protara-therapeutics-announces-it-achieves-clinical-success-with-one-or-two-doses-of-tara-002-in-phase-2-starborn-1-study-in-88-of-participants-no-serious-adverse-events-seen
Protara Therapeutics Announces It Achieves...
11/19/2025 13:06:39

Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of ca...

protara-therapeutics-to-review-new-data-from-interim-analysis-of-ongoing-phase-2-open-label-starborn-1-trial-assessing-tara-002-in-pediatric-patients-with-lms-on-november-19-conference-call
Protara Therapeutics To Review New Data Fr...
11/18/2025 21:33:58

Protara Therapeutics, Inc. (NASDAQ:TARA), a clinical-stage company developing transformative therapies for the treatment of can...

protara-therapeutics-to-present-interim-data-from-group-a-of-phase-2-advanced-2-study-of-tara-002-in-bcg-naive-participants-with-non-muscle-invasive-bladder-cancer
Protara Therapeutics To Present Interim Da...
11/17/2025 13:07:52

Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of ca...

protara-therapeutics-q3-eps-031-beats-038-estimate
Protara Therapeutics Q3 EPS $(0.31) Beats ...
11/10/2025 13:14:29

Protara Therapeutics (NASDAQ:TARA) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of ...

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
09/22/2025 12:09:30

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/28/2025 21:06:27

protara-therapeutics-q2-eps-035-beats-041-estimate
Protara Therapeutics Q2 EPS $(0.35) Beats ...
08/11/2025 12:15:20

Protara Therapeutics (NASDAQ:TARA) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of ...

protara-therapeutics-announces-addition-to-russell-3000-index
Protara Therapeutics Announces Addition To...
06/30/2025 12:10:08

jones-trading-initiates-coverage-on-protara-therapeutics-with-buy-rating-announces-price-target-of-21
Jones Trading Initiates Coverage On Protar...
05/22/2025 15:04:45

Jones Trading analyst Soumit Roy initiates coverage on Protara Therapeutics (NASDAQ:TARA) with a Buy rating and announces Pr...

protara-therapeutics-q1-eps-029-beats-045-estimate
Protara Therapeutics Q1 EPS $(0.29) Beats ...
05/08/2025 12:08:01

Protara Therapeutics (NASDAQ:TARA) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of ...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
04/28/2025 17:05:53

crude-oil-down-2-roper-technologies-increases-2025-outlook
Crude Oil Down 2%; Roper Technologies Incr...
04/28/2025 16:38:56

dow-jumps-over-150-points-dominos-pizza-posts-upbeat-earnings
Dow Jumps Over 150 Points; Domino's Pizza ...
04/28/2025 13:56:16

hc-wainwright--co-reiterates-buy-on-protara-therapeutics-maintains-23-price-target
HC Wainwright & Co. Reiterates Buy on Prot...
04/28/2025 11:50:38

HC Wainwright & Co. analyst Andres Maldonado reiterates Protara Therapeutics (NASDAQ:TARA) with a Buy and maintains $23 ...

reported-saturday-protara-therapeutics-shares-interim-results-highlighting-durable-clinical-responses-with-tara-002-in-high-risk-nmibc
Reported Saturday, Protara Therapeutics Sh...
04/28/2025 07:19:47

TARA-002 demonstrates 100% complete response rate at any time and 67% 12-month landmark complete response rate in BCG-Unrespons...

protara-therapeutics-announces-conference-call-and-webcast-to-review-interim-data-from-phase-2-advanced-2-trial-of-tara-002-in-patients-with-nmibc-on-monday-april-28-2025
Protara Therapeutics Announces Conference ...
04/23/2025 12:05:48

NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (NASDAQ:TARA), a clinical-stage company developing tran...

this-hb-fuller-analyst-turns-bullish-here-are-top-5-upgrades-for-thursday
This H.B. Fuller Analyst Turns Bullish; He...
04/17/2025 11:53:40

this-urogen-pharma-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday
This UroGen Pharma Analyst Begins Coverage...
04/16/2025 13:27:15

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION